{"id":194014,"name":"SCILEX HOLDING COMPANY","slug":"scilex-holding-company","state":"CA","country":"United States of America","description":"Pharmaceutical company; subsidiary of Sorrento Therapeutics","totalSpending":480000,"filings":14,"yearlySpending":[{"year":2019,"income":100000},{"year":2020,"income":250000},{"year":2021,"income":130000}],"issues":["HCR","MMM"],"firms":["TAUZIN CONSULTANTS, LLC"],"lobbyists":["THOMAS TAUZIN","MICHAEL MEIROVITZ","MIMI SIMONEAUX KNEUER","ROGER ADAMS"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Food & Drug Administration (FDA)"],"sampleDescriptions":["Issues related to the opioid crisis.","Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).","Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD).","Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD); and","Issues related to fair competition, the generic drug market, drug costs, pain management, S.1895, the Lower Health Care Costs Act; Patient Affordability Value and Efficiency Act (bill number TBD); and"],"years":[2019,2020,2021]}